Case Report: ACTH-independent Cushing’s syndrome caused by isolated micronodular adrenal disease in a 23-month-old girl - Top-Institutions - MDSpire

Case Study: Isolated Micronodular Adrenal Disease Leading to ACTH-Independent Cushing’s Syndrome in a 23-Month-Old Female Patient

  • By

  • Marta Valério

  • Gonçalo P. Croca

  • Joana Simões

  • Patricia Ferreira

  • Durval C. Costa

  • Maria Knoblich

  • Julia Galhardo

  • July 21, 2026

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health Clinical Center
    National Institutes of Health Clinical Center

    Bethesda, Maryland

    Key Differentiators

    • Endocrinology
    • Pediatric Endocrinology

  • #2

    Istanbul University-Cerrahpasa
    Istanbul University-Cerrahpasa

    Istanbul, Turkey

    Key Differentiators

    • Endocrinology

  • #3

    Tertiary Hospital in Germany
    Tertiary Hospital in Germany

    Berlin, Germany

    Key Differentiators

    • Endocrinology

  • #4

    University of Alabama at Birmingham
    University of Alabama at Birmingham

    Birmingham, Alabama

    Key Differentiators

    • Endocrinology

  • #5

    Endocrinology Department
    Endocrinology Department

    Unknown, Unknown

    Key Differentiators

    • Endocrinology

Original Source(s)

Case Report: ACTH-independent Cushing’s syndrome caused by isolated micronodular adrenal disease in a 23-month-old girl

  • by Marta Valério, Gonçalo P. Croca, Joana Simões, Patricia Ferreira, Durval C. Costa, Maria Knoblich, Julia Galhardo

  • July 21, 2026

Related Content

Declining Bariatric Surgery Volumes and Shifting Practice Patterns: A Five-Year Analysis of Over One Million Procedures

Virtual Preoperative Education in Bariatric Surgery: Patient Acceptance and Travel-Related Carbon Savings

GLP-1 RAs Associated With Small ION Risk Increase

In an observational US target trial emulation, glucagon-like peptide-1 receptor agonist initiation was associated with about 3 to 4 more ischemic optic neuropathy cases per 10,000 patients over 18 months than two comparator drug classes.